| 发明名称 | Myocardial perfusion imaging methods and compositions | ||
| 摘要 | A myocardial imaging method that is accomplished by administering one or more adenosine A2A adenosine receptor agonist to a human undergoing myocardial imaging as well as pharmaceutical compositions comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent. | ||
| 申请公布号 | US9289446(B2) | 申请公布日期 | 2016.03.22 |
| 申请号 | US201414533025 | 申请日期 | 2014.11.04 |
| 申请人 | Gilead Sciences, Inc. | 发明人 | Belardinelli Luiz;Rosner Mitchell |
| 分类号 | A01N43/04;A61K31/70;A61K51/00;A61K49/00;A61K31/7076;A61K51/04;A61K47/10 | 主分类号 | A01N43/04 |
| 代理机构 | Sheppard Mullin Richter & Hampton LLP | 代理人 | Sheppard Mullin Richter & Hampton LLP |
| 主权项 | 1. A pharmaceutical composition comprising: a) about 400 μg of a compound which has the formula: b) at least one liquid carrier selected from the group consisting of water, saline, a buffer, and combinations thereof, c) at least one sodium phosphate buffer; d) EDTA; and e) propylene glycol in an amount of about 15% (w:v),wherein the pH of said pharmaceutical composition is from about 6 to about 8. | ||
| 地址 | Foster City CA US | ||